Former headquarters of Roussel-Uclaf, 35 Boulevard des Invalides, 7th arrondissement of Paris
Company type
Public (Société anonyme)
Industry
Pharmaceutical
Founded
Paris, France (1911 (1911)) Institut de Sérothérapie Hémopoïétique ISH (1920) Usines Chimiques des Laboratoires Français UCLAF (1928) Société Française de la Pénicilline SOFRAPEN (1947) (Roussel-Uclaf, S.A. incorporated 1961)
Founder
Gaston Roussel
Defunct
September 30, 1997 (September 30, 1997)[1]
Fate
Acquired
Successor
Hoechst AG (Hoechst Marion Roussel)
Headquarters
Paris, France (1911–1995) Romainville, France (1995–1997)[2]
15,673 worldwide (1992)[4] 8,409 in France (1992)[4] 6,533 in France (1996)[5]
Roussel Uclaf S.A. was a French pharmaceutical company and one of several predecessor companies of today's Sanofi.
It was the second largest French pharmaceutical company[6] before it was acquired by Hoechst AG of Frankfurt, Germany in 1997, with pharmaceutical operations combined into the Hoechst Marion Roussel (HMR) division in the United States. Roussel Uclaf's agrochemical operations had been transferred to Hoechst Schering AgrEvo GmbH in 1994.
HMR subsequently merged in 1999 with Rhône-Poulenc to form Aventis, which then merged in 2004 with Sanofi-Synthélabo to form Sanofi-Aventis, which was since renamed Sanofi. Hoechst Schering AgrEvo merged in 1999 with Rhône-Poulenc's agrochemical division to form Aventis CropScience, which was acquired by Bayer AG in 2002 and combined with Bayer's agrochemical division to form Bayer CropScience.
^Flallo, Laurent (October 2, 1997). "Hoechst Marion Roussel France touché par une des taxes Aubry". Les Échos. p. 8. Hoechst Marion Roussel France - ex-Roussel Uclaf, which juridically disappeared yesterday...
^Aizicovici, Francine (March 7, 1994). "Le désarroi des salariés". Le Monde. headquarters moved to Romainville in April 1995 after 40 years at 35 Boulevard des Invalides, Paris.
^ ab"Roussel UCLAF: profits en hausse de 11%". l'Humanité. February 18, 1997. "Hoechst AG: Roussel Uclaf unit posts net profit increase of 90%". The Wall Street Journal. February 18, 1997. p. A6. 1996: $3.01 billion sales, $339.5 million net profit
^ ab"Country focus: French chemicals: an industry review". Chemical Week. May 5, 1993. p. S14.
Roussel Uclaf Sales 1992: F14.8 billion (3.5%). Profit before tax 1992: F1.439 billion (43%). Investment in assets 1992: F930 million (11.8%). Acquisitions in 1992: F452 million. Employees: 15,673; 8,409 of whom are in France. Principal products: Pharmaceuticals (57% of sales), agroveterinary products (23%), bulk pharmaceuticals (13%) and OTC and cosmetics (4%). Roussel Uclaf is owned 65% by Hoechst and 35% by Rhone-Poulenc, which might soon sell its stake to Hoechst. Headquarters: Paris.
^Lemaître, Frédéric (December 3, 1996). "Roussel-Uclaf adopte les 35 heures de travail hebdomadaires sans perte de salaire". Le Monde. 6,533 employees in France
^"Roussel Uclaf disappears, giving way to Hoechst Marion Russell". Chemical Business NewsBase. Cambridge: Royal Society of Chemistry. October 14, 1997. 2nd largest pharmaceutical company (after Rhône-Poulenc and ahead of Sanofi)
RousselUclaf S.A. was a French pharmaceutical company and one of several predecessor companies of today's Sanofi. It was the second largest French pharmaceutical...
Julien Gaston Roussel, who was President and General Manager of the RousselUclaf Laboratoires Pharmaceutiques, and his wife, Francine Grinda, daughter...
mifepristone for personal use in 1989, a decision supported by RousselUclaf. In 1994, RousselUclaf gave the U.S. drug rights to the Population Council in exchange...
Paris. He later obtained an MBA at HEC Paris. In April 1986, he joined RousselUclaf (formerly France's second largest pharmaceutical company, until bought...
Merrell Dow of Kansas City, Missouri forming U.S. subsidiary Hoechst Marion Roussel (HMR). 1997 — Hoechst underwent a realignment wherein its various businesses...
French automobile manufactured from 1908 to 1914 RousselUclaf, a French pharmaceutical company Big Roussel, the channel between Herm to the west, and Brecqhou...
& Company). Hoechst's new pharmaceutical company became Hoechst Marion Roussel and kept its North American headquarters in Kansas City. Hoechst in turn...
corporation Hoechst Marion Roussel, which itself was formed from the 1995 merger of Hoechst AG with Cassella, RousselUclaf, and Marion Merrell Dow. Hoechst...
less sedative or muscle relaxant action. It was developed by a team at RousselUclaf in the 1990s Tully WR, Gardner CR, Gillespie RJ, Westwood R (July 1991)...
anti-mineralocorticoids. The main active companies were Searle, Ciba-Geigy, RousselUclaf and Schering AG. Around 50 years after Selye's work, several pharmaceutical...
preparation]", published 1969-07-24, assigned to Roussel-Uclaf U.S. patent 3,644,368 RousselUclaf Mouzin G, Cousse H, Autin JM (1980). "A New, Convenient...
Choice Act, and announced a boycott of the French pharmaceutical company RousselUclaf and its American affiliates for permitting its abortion drug, mifepristone...
sold. The drug appears to have been an early development project of RousselUclaf, a French pharmaceutical company, and by the early 1970s, it was being...
Roxithromycin's half-life is 12 hours. French pharmaceutical company RousselUclaf first marketed roxithromycin in 1987. Fischer J, Ganellin CR (2006)...
Matsumoto married Jean-Claude Cathalan, who, at the time, was a manager at RousselUclaf He later became the president of Revillon, Parfums Caron, Jean-Louis...
1990 UCLA School of Medicine Award for Excellence in Education. 1993 RousselUclaf Prize for Cell Communication and Signaling. Shared with Dr. Salvador...
in Milan and was first published in 1969; Maestretti was acquired by RousselUclaf which became part of Sanofi. "FDA-sourced list of all drugs with black...
Oflocet in France, Portugal, Tunisia, and several African countries by Roussel-Uclaf, as Oflocin by Glaxo in Italy, and as Flobacin by Sigma-Tau in Italy...
assigned to Roussel-Uclaf GB 1024156, "Process for the preparation of 5-iodo-2'-desoxy-uridine", published 1966-03-30, assigned to Roussel-Uclaf Cheong...
from 1956. Merck and RousselUclaf concentrated on improving the production of corticosteroids from cattle bile acids. In 1960 Roussel produced almost one-third...
forceps-like instrument, known as a cranioclast. In 1980, researchers at RousselUclaf in France developed mifepristone, a chemical compound which works as...
universities of Cologne and Kent. In 1988, she completed an internship at RousselUclaf in Paris. After university, Slomka worked from 1991 to 1996 for Cologne...
chloramphenicol first introduced by RousselUclaf in 1954; marketed as Tifomycine, it was originally used as a treatment for typhoid. Roussel stopped production of...
and a long-acting prodrug of trenbolone. The drug was described by RousselUclaf in 1967 and was the first long-lasting ester of trenbolone to be developed...
hours after announcing it was abandoning RU-486, French manufacturer RousselUclaf states that it will resume distribution of the drug. October 29 – Pakistan's...
Global Information
US$ 3.01 billion (1996)[3]